Head of Clinical Research
Dr. Jo Milton is the Head of Clinical Research, responsible for the operational management of the unit's research portfolio and leadership of the trial and data management sections, ensuring that trials are conducted to the highest regulatory, ethical and scientific standards.
Jo has over ten years of experience in project managing phase II to IV clinical trials in diabetes and endocrinology, oncology and paediatrics. Jo joined the Diabetes Trials Unit in 2010 as Project Manager for the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) and subsequently managed Translational Research Group (TRG) trials following the close-out of TECOS in 2015.
Originally training as a Dietitian, Jo went on to obtain her doctorate in nutrition from Imperial College, London, in 2007. Her professional interests include public and patient involvement and research ethics; Jo is a member of Berkshire B Research Ethics Committee and the UK Trial Manager's Network Oxford Hub working group.
Outside of work Jo enjoys hiking, photography, dancing and gardening.
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure.
Hundertmark MJ. et al, (2021), ESC Heart Fail, 8, 2580 - 2590
Stimulatory effects of the long-acting kisspeptin analogue TAK-448 on serum testosterone in men with type 2 diabetes and hypogonadotropic hypogonadism
George JT. et al, (2016), DIABETOLOGIA, 59, S228 - S228
An exploration into the proportion of carbohydrate used in the calculation of diet glycaemic index (GI) for which GI values are published or estimated.
Philippou E. et al, (2006), PROCEEDINGS OF THE NUTRITION SOCIETY, 65, 59A - 59A
Nutritional influences on gut hormone release
Frost G. et al, (2006), Current Opinion in Endocrinology and Diabetes, 13, 42 - 48